Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
about
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerPartial response to sorafenib treatment associated with transient grade 3 thrombocytopenia in a patient with locally advanced thyroid cancer.Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib.Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.Comparison of ¹⁸F-fluoride PET/CT, ¹⁸F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot studyPrognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.Development of skin hypopigmentation in a patient with metastatic papillary carcinoma thyroid treated with SorafenibSorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trialChanges in the pulmonary function test after radioactive iodine treatment in patients with pulmonary metastases of differentiated thyroid cancer.Standard and emerging therapies for metastatic differentiated thyroid cancer.Clinicopathological features of recurrent papillary thyroid cancer.Novel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasionEvaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis.Femoral pathological fracture as the first clinical manifestation of papillary thyroid carcinoma in a primigravidaThe impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland.Phase II trial of sorafenib in advanced thyroid cancer.The impact of complete surgical resection of spinal metastases on the survival of patients with thyroid cancer.Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elementsLong-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors.Clinical features of bone metastasis for differentiated thyroid carcinoma: A study of 21 patients from a Tunisian center.Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis.Long-term outcomes of distant metastasis from differentiated thyroid carcinoma.Surgical management of appendicular skeletal metastases in thyroid carcinoma.Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus.Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation.Impact of patient age on the iodine/FDG "flip-flop" phenomenon in lung metastasis from thyroid cancer.Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.Intermediate-risk differentiated thyroid carcinoma patients who were surgically ablated do not need adjuvant radioiodine therapy: long-term outcome study.MRI and ultrasonography detection of cervical lymph node metastases in differentiated thyroid carcinoma before reoperation.Management of Invasive Differentiated Thyroid Cancer.Insular thyroid cancer: a population-level analysis of patient characteristics and predictors of survival.Prognostic implications of radioiodine avidity and serum thyroglobulin in differentiated thyroid carcinoma with distant metastasis.Acute paraparesis as presentation of an occult follicular thyroid carcinoma: A case report.Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up.The influence of neural cell adhesion molecule isoform 140 on the metastasis of thyroid carcinoma.Lung metastases from differentiated thyroid carcinoma: prognostic factors related to remission and disease-free survival.Downregulated expression of TSHR is associated with distant metastasis in thyroid cancer.Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program.
P2860
Q30367068-9265EC0B-AC5E-430D-A7A4-1D555ED8A336Q33425571-DC6339FD-70BC-4EA1-B077-C073B62CD19CQ33682381-7DF9F0FC-A3F0-4104-A85B-6683AB3E90E8Q33704207-708C5C61-B163-441F-9664-7BF740D6E7AAQ33782049-FC36B74C-68C7-4216-95C3-5DDD0B21636AQ34041618-131E3243-8131-4BBF-B801-C332122AADD2Q34929133-BA6D02F2-F235-487E-A0CD-512C924C8660Q35195766-60F260C3-4834-4020-9D7E-1EC160D927ABQ35553559-B93B4E02-A339-4FB9-B8D4-FFC8F717EDA4Q35583906-34CB39A6-44F4-4B99-A2B2-A924F25476D9Q35848625-54822B5D-49D1-4E1E-AFD8-E6F774D06245Q36451879-E249F597-D73E-43E2-9F4E-15D8E3B2480CQ36689253-5E2A6339-8A35-419E-A134-49B6822E550FQ36801484-CC9E2A53-1D7A-4979-A37C-FD8BD8FA29FBQ37022492-7D894F26-0A35-4F35-9A9E-A70C611DA019Q37121708-A63EAB37-E122-4793-83D0-CA94E1759967Q37321115-022E7C6F-FAC7-4972-BC7C-F8A81F106516Q37505185-16C2458B-8834-4EAE-9604-64DCDDC2D690Q37587879-9470F718-F7F5-4527-8E25-338B729EF792Q37703697-BCC69632-F8C0-4BF8-BDD5-4744B2FEAE85Q37873377-C719E909-BEFD-42BA-BBF9-6537DEBECC6EQ37939266-1D6143A9-CFA7-4FE2-9033-A59A54B196F0Q38072936-4F577FEC-5EF6-492B-8CE7-08E71379998EQ38119437-2304A385-93F5-42D4-8C0A-D395C874CB43Q38243095-D0683821-0127-42AE-A104-7ED80968D925Q38439427-CDB0A440-F261-49C9-B1F3-F53CB5D55FEBQ39360671-CC47B04A-7CBA-4479-93F2-00A58975E78BQ39630410-CBE6319F-E69D-47B3-9760-4C7E824A3669Q40620042-9E1B85A8-02CD-4BDE-90E6-1D2429DBD9A4Q41139698-C255F398-A24D-4600-9556-27BA024C8E0DQ41891555-A807894C-5085-4A9B-800D-E69891A78E1AQ41912985-EE141298-1CC5-4AC5-B4CB-288C651E6DADQ43473938-CBC9DBB4-08B9-47F3-A69D-C969940FAA08Q45772461-5710F1E3-522F-4DAA-A729-B810565628EEQ47122479-FF00461E-1324-4E81-98BD-12AF335ADCF0Q48252662-9D4C2C97-2B4C-4955-ABD8-75A4C5D5D95DQ48605433-6368F756-F02E-4E74-9C7F-2BBC99C3EE5AQ48650703-C3DA6B86-6CD2-4D7A-8392-3477FA4A8B65Q49364377-03A83857-D703-402E-B474-0EBFC0155174Q49377077-C1B8EE5B-2F6B-4F13-929F-3775E4463A2F
P2860
Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prognostic indicators of outco ...... ferentiated thyroid carcinoma.
@ast
Prognostic indicators of outco ...... ferentiated thyroid carcinoma.
@en
type
label
Prognostic indicators of outco ...... ferentiated thyroid carcinoma.
@ast
Prognostic indicators of outco ...... ferentiated thyroid carcinoma.
@en
prefLabel
Prognostic indicators of outco ...... ferentiated thyroid carcinoma.
@ast
Prognostic indicators of outco ...... ferentiated thyroid carcinoma.
@en
P2093
P1476
Prognostic indicators of outco ...... fferentiated thyroid carcinoma
@en
P2093
Alexander Stojadinovic
Ashok R Shaha
Aviram Nissan
Margo Shoup
Ronald A Ghossein
Sam Freedman
P304
P356
10.1016/S1072-7515(03)00332-6
P577
2003-08-01T00:00:00Z